Methods and Protocols
edited by C. Mark Smales
Therapeutic Proteins shares innovative and proven techniques for the production of therapeuic proteins downstream of the discovery stage.
Protocols follow the successful Methods in Molecular Biology™ series format, each offering step-by-step laboratory instructions, an introduction outlining the principles behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls.
Contents
- Biopharmaceutical Proteins: Opportunities and Challenges
- Expression of Antibody Fragments by Periplasmic Secretion in Escherichia coli
- Secretory Production of Therapeutic Proteins in Escherichia coli
- Expression of Recombinant LTB Protein in Marine vibrio VSP60
- Heterologous Gene Expression in Yeast
- Pharmaceutical Proteins From Methylotrophic Yeasts
- Expression of Human Papillomavirus Type 16 L1 in Baculovirus Expression Systems: A Case Study
- Large-Scale Transient Expression of Therapeutic Proteins in Mammalian Cells
- Site-Specific Integration for High-Level Protein Production in Mammalian Cells
- Production of Recombinant Therapeutic Proteins by Mammalian Cells in Suspension Culture
- Transgene Control Engineering in Mammalian Cells
- Fusion to Albumin as a Means to Slow the Clearance of Small Therapeutic Proteins Using the Pichia pastoris Expression System: A Case Study
- High-Throughput Recovery of Therapeutic Proteins from the Inclusion Bodies of Escherichia coli: An Overview
- Isolation, Solubilization, Refolding, and Chromatographic Purification of Human Growth Hormone from Inclusion Bodies of Escherichia coli Cells: A Case Study
- Large-Scale Preparation of Factor ViIa from Human Plasma: A Case Study
- Purification of Clinical-Grade Monoclonal Antibodies by Chromatographic Methods
- Virus Elimination and Validation
- Virus Removal by Nanofiltration
- Determining Residual Host Cell Antigen Levels in Purified Recombinant Proteins by Slot Blot and Scanning Laser Densitometry
- Principles of Biopharmaceutical Protein Formulation: An Overview
- Solid-State Protein Formulation: Methodologies, Stability, and Excipient Effects
- Stabilization of Therapeutic Proteins by Chemical and Physical Methods
- Extraction and Characterization of Vaccine Antigens from Water-in-Oil Adjuvant Formulations
- Probing Reversible Self-Association of Therapeutic Proteins by Sedimentation Velocity in the Analytical Ultracentrifuge
- Biological Characterization of Pegylated Interferons: A Case Study
- Characterization of Interferon a2B Pegylated via Carboxyalkylation: A Case Study
- Quantifying Recombinant Proteins and Their Degradation Products Using SDS-PAGE and Scanning Laser Densitometry
- Extraction and Denaturing Gel Electrophoretic Methodology for the Analysis of Yeast Proteins
- Characterization of Therapeutic Proteins by Membrane and In-Gel Tryptic Digestion
- Oligosaccharide Release and MALDI-TOF MS Analysis of N-Linked Carbohydrate Structures from Glycoproteins
- Capillary Electrophoresis of Carbohydrates Derivatized With Fluorophoric Compounds
- High-Throughput LC/MS Methodology for a(1Æ3)Gal Determination of Recombinant Monoclonal Antibodies: A Case Study
- Carbohydrate Structural Characterization of Fas Ligand Inhibitory Protein
- Top-Down Characterization of Protein Pharmaceuticals by Liquid Chromatography/Mass Spectrometry: Application to Recombinant Factor IX Comparability– A Case Study
- Sample Preparation Procedures for High-Resolution Nuclear Magnetic Resonance Studies of Aqueous and Stabilized Solutions of Therapeutic Peptides
Index